Filing Details
- Accession Number:
- 0001104659-20-060287
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-12 18:25:50
- Reporting Period:
- 2020-05-08
- Accepted Time:
- 2020-05-12 18:25:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1554859 | Semler Scientific Inc. | SMLR | Electromedical & Electrotherapeutic Apparatus (3845) | 261367393 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1594346 | E Daniel Conger | C/O Semler Scientific, Inc. 911 Bern Court, Suite 110 San Jose CA 95112 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-05-08 | 3,000 | $2.59 | 3,000 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-05-08 | 10,000 | $3.44 | 13,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-05-11 | 12,420 | $40.11 | 580 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-05-11 | 580 | $41.99 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-08 | 3,000 | $0.00 | 3,000 | $2.59 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-08 | 10,000 | $0.00 | 10,000 | $3.44 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-12-31 | No | 4 | M | Direct | |
0 | 2025-07-20 | No | 4 | M | Direct |
Footnotes
- The price reported is a weighted average price. The shares were sold at prices ranging from $40.00 to $41.00. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The price reported is a weighted average price. The shares were sold at prices ranging from $41.25 to $42.20. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Fully vested and exercisable.